Clinical Trial Update: Evaluation Of The Ability Of Fesoterodine To Increase Urethral Pressure In Stress Urinary Incontinence Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether fesoterodine can increase urethral pressure in patients with stress urinary incontinence; the study is completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence

Drugs mentioned

• Toviaz (fesoterodine fumarate)

Snippet

Sponsor: Pfizer | Conditions: Stress Urinary Incontinence | Phase 2 | Status: COMPLETED | Results posted: 2011-07-01